Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.

Belyakov IM, Derby MA, Ahlers JD, Kelsall BL, Earl P, Moss B, Strober W, Berzofsky JA.

Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1709-14.

3.

Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections.

Berzofsky JA, Ahlers JD, Derby MA, Pendleton CD, Arichi T, Belyakov IM.

Immunol Rev. 1999 Aug;170:151-72. Review.

PMID:
10566149
4.

Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.

Belyakov IM, Ahlers JD.

Curr Top Microbiol Immunol. 2012;354:157-79. doi: 10.1007/82_2010_119. Review.

PMID:
21203884
5.
6.

Recent progress in HIV vaccines inducing mucosal immune responses.

Pavot V, Rochereau N, Lawrence P, Girard MP, Genin C, Verrier B, Paul S.

AIDS. 2014 Jul 31;28(12):1701-18. doi: 10.1097/QAD.0000000000000308. Review.

PMID:
25009956
7.

HIV vaccines: a brief overview.

Lema D, Garcia A, De Sanctis JB.

Scand J Immunol. 2014 Jul;80(1):1-11. doi: 10.1111/sji.12184. Review.

8.

Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection.

Poles J, Alvarez Y, Hioe CE.

AIDS Res Hum Retroviruses. 2014 Nov;30(11):1027-40. doi: 10.1089/aid.2014.0233. Review.

9.

Cytotoxic T-lymphocyte-, and helper T-lymphocyte-oriented DNA vaccination.

Nagata T, Aoshi T, Uchijima M, Suzuki M, Koide Y.

DNA Cell Biol. 2004 Feb;23(2):93-106. Review.

PMID:
15000749
10.

Cytotoxic and helper T-lymphocyte responses to antibody recognition regions on influenza virus hemagglutinin.

Atassi MZ, Torres JV, Wyde PR.

Adv Exp Med Biol. 1989;251:49-63. Review.

PMID:
2532857
11.

Translational Mini-Review Series on Vaccines for HIV: T lymphocyte trafficking and vaccine-elicited mucosal immunity.

Kaufman DR, Barouch DH.

Clin Exp Immunol. 2009 Aug;157(2):165-73. doi: 10.1111/j.1365-2249.2009.03927.x. Review.

12.
13.

Mucosal immunization: a review of strategies and challenges.

Patel H, Yewale C, Rathi MN, Misra A.

Crit Rev Ther Drug Carrier Syst. 2014;31(4):273-303. Review.

PMID:
25072196
14.

Effector and memory CTL differentiation.

Williams MA, Bevan MJ.

Annu Rev Immunol. 2007;25:171-92. Review.

PMID:
17129182
15.

Vaccines for mucosal immunity to combat emerging infectious diseases.

van Ginkel FW, Nguyen HH, McGhee JR.

Emerg Infect Dis. 2000 Mar-Apr;6(2):123-32. Review.

16.

Contemporary HIV Vaccines: Tissue Resident T-Cells and Strategies to Prevent Mucosal Infection.

Tan HX, Kent SJ, De Rose R.

Curr Top Med Chem. 2016;16(10):1107-17. Review.

PMID:
26324042
17.
18.

Requirement of immune system heterogeneity for protective immunity.

Durlanik S, Thiel A.

Vaccine. 2015 Sep 29;33(40):5308-12. doi: 10.1016/j.vaccine.2015.05.096. Review.

PMID:
26073012
19.

Evidence for a common mucosal immune system in the pig.

Wilson HL, Obradovic MR.

Mol Immunol. 2015 Jul;66(1):22-34. doi: 10.1016/j.molimm.2014.09.004. Review.

PMID:
25242212

Supplemental Content

Support Center